Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,077.7
-22.6 (-0.73%)

 

  • STI Straits Times Index
    3,077.7
    -22.6 (-0.73%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,546.8
    13.8 (0.90%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,500.4
    291.6 (1.20%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,602.2
    19.4 (0.54%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    30,184.0
    -56.1 (-0.19%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,113.1
    -9.4 (-0.15%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,534.8M
  • Value: 1,266.0M
  • Rise: 150
  • Fall: 179
  • Unch: 426

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.082+0.001
FJ Benjamin0.030+0.004
RH PetroGas0.157+0.022
Hatten Land0.061+0.006
Rex Intl0.215+0.015
Blumont0.005-
Singtel2.480-0.030
Genting Sing0.720-0.025
YZJ Shipbldg SGD1.390-0.010
ThaiBev0.655-

World Indices

World Indices
Name Last Change
Nasdaq 14,970.0 -77.7
HSI 24,500.4 +291.6
HSCEI 8,720.3 +136.5
Jakarta 6,113.1 -9.4
Nikkei 225 30,184.0 -56.1
SSE Comp 3,602.2 +19.4
Shanghai A 3,775.3 +20.3
Shanghai B 274.8 +3.7
KOSPI 3,097.9 -35.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

TalkMed TALKMED GROUP LIMITED
Quotes 10 Minutes Delayed. Updated at 28 Sep 2021 17:00
Last (SGD): 0.390 Change: - High: - Remarks: -
Change (%): - Low: -
Open - Yesterday's Close 0.390
Buy Price 0.390 Sell Price 0.410
Buy Volume ('000) 25.6 Sell Volume ('000) 0.2
Cumulative Volume ('000) - Cumulative Value -
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.01725 Trailing EPS (SGD) e 0.01733 NAV (SGD) b 0.0642
PE a 22.609 Trailing PE f 22.498 Price / NAV b 6.0748
Dividend (SGD) d 0.013479 Cash In Hand (SGD) g 0.0613 Issued & Paid-up Shares c 1,320,109,000
Dividend Yield (%) d 3.456 Price / Cash In Hand g 6.362 Treasury Shares h -
Beta - 75 Daysi -0.019 R-Squared - 75 Days(%)i 0.04 Market Cap (M) 514.843
Beta - 500 Daysi 0.263 R-Squared - 500 Days (%)i 1.93 Enterprise Value (M) 436.474
Piotroski F Score 3 Exchange Code 5G3 Par Value ( SGD ) n.a.
52 Weeks Volatility (%) 23.4843 6-Month VWAP 0.410 Free Float (%) 16.7
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Health and Social Services - Medical/Nursing Services
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. The figure pertains to the respective exchange the stock is listed on. Updated on 05 Aug 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference TalkMed SGX 514.843 22.609 22.498 6.0748 3.456
Industry Medical & Biotechnology SGX 1,011.400 18.699 15.966 1.4242 3.012
Medical/Nursing Services SGX 99.191 23.147 28.385 2.3514 3.101
Index FTSE ST Catalist Index SGX 61.051 30.292 22.700 1.3699 1.908
Local Peer Asian Healthcare SGX 92.923 35.941 25.862 1.8066 0.736
Local Peer Cordlife SGX 95.738 14.626 14.945 0.7220 2.393
Local Peer HC Surgical SGX 81.891 10.236 10.236 8.3333 7.273
Local Peer Clearbridge SGX 71.597 116.000 - 1.1658 -
Local Peer Alliance HC SGX 36.796 24.016 24.018 1.9094 1.299
Local Peer Sing Paincare SGX 35.925 16.327 16.329 1.5256 3.750
Local Peer Medinex SGX 28.866 8.264 8.264 1.7323 7.636
Local Peer AsiaMedic SGX 17.912 - - 2.0000 -
Local Peer RHT HealthTrust SGX 15.417 - - 0.9453 -
Global Peer JD HEALTH HKEx 240,570.935 - - 5.0609 -
Global Peer FRESENIUS MEDICAL CARE AG & CO KGAA SPON ADR-EACH REP 0.5 NPV NYSE 20,966.472 15.796 17.655 1.5199 1.601
Global Peer SONIC HEALTHCARE ASX 18,923.605 14.390 14.390 2.9638 2.298
Global Peer GUARDANT HEALTH INC NASDAQ 12,735.310 - - 16.1602 -
Global Peer DAVITA INC NYSE 12,647.264 16.146 14.318 9.8978 -
Global Peer OAK STREET HEALTH INC NYSE 11,358.910 - - 52.1797 -
Global Peer NATERA INC NASDAQ 10,796.310 - - 36.0946 -
Global Peer AGILON HEALTH INC NYSE 10,546.023 - - 9.1669 -
Global Peer CHEMED CORP NYSE 7,414.885 23.210 24.440 8.5153 0.283
Global Peer CANO HEALTH INC NYSE 6,767.788 - - 19.2098 -
Other Global Peers INVITAE CORP (NYSE), ACADIA HEALTHCARE (NASDAQ), NEOGENOMICS INC (NASDAQ), LIFESTANCE HEALTH GROUP INC (NASDAQ), LHC GROUP INC (NASDAQ), AMEDISYS INC (NASDAQ), OPTION CARE HEALTH INC (NASDAQ), ENSIGN GROUP INC (NASDAQ), JXR (HKEx), JXR-2000 (HKEx), 1LIFE HEALTHCARE INC (NASDAQ), FULGENT GENETICS INC (NASDAQ), MEDNAX INC (NYSE), SMILEDIRECTCLUB INC (NASDAQ), HEALIUS LTD (ASX), NH HEALTH-B (HKEx), CASTLE BIOSCIENCES INC (NASDAQ), BURNING ROCK BIOTECH LTD SPON ADS EACH REP 1 ORD SHS CL A (NASDAQ), EC HEALTHCARE (HKEx), RADNET INC (NASDAQ), US PHYSICAL THERAPY (NYSE), AVEANNA HEALTHCARE HOLDINGS INC (NASDAQ), ADDUS HOMECARE CORP (NASDAQ), APRIA INC (NASDAQ), GENETRON HOLDINGS LIMITED SPON ADS EACH REP 5 ORD SHS (NASDAQ), C-MER EYE (HKEx), TIVITY HEALTH INC (NASDAQ), SVH (SET), KPJ (Bursa), RAM (SET), Metro Healthcare Indonesia Tbk. (IDX), PENNANT GROUP INC (NASDAQ), HANGER INC (NYSE), CHAOJU EYE CARE (HKEx), ATI PHYSICAL THERAPY INC (NYSE), OCEANIA HEALTHCARE LTD (ASX), KINDSTAR GLOBAL (HKEx), AUSTRALIAN CLINICA (ASX), FINCH THERAPEUTICS GROUP INC (NASDAQ), TOWN HEALTH (HKEx), GLOBAL CORD BLOOD CORPORATION (NYSE), EUROEYES (HKEx), UPHEALTH INCORPORATED (NYSE), VIRTUS HEALTH LIMITED (ASX), GLOBAL X FDS ARTIFICIAL INTELLIGENCE AND TECH ETF (NASDAQ), SERA PROGNOSTICS INC (NASDAQ), CARDIFF ONCOLOGY INC (NASDAQ), FIELD TRIP HEALTH LTD (NASDAQ), SANARA MEDTECH INC (NASDAQ), BIODESIX INC (NASDAQ), EXAGEN INC (NASDAQ), AKUMIN INC (NASDAQ), ONTRAK INC (NASDAQ), CLOVER CORP (ASX), APTINYX INC (NASDAQ), OPTINOSE INC (NASDAQ), SILK LASER AUSTRALIA LTD (ASX), HEALTHIA LTD (ASX), CAPITAL SENIOR LIVING CORP (NYSE), GREENBROOK TMS INC (NASDAQ), KANGHUA HEALTH (HKEx), PROGENITY INC (NASDAQ), OPTIMAX (Bursa), PRO-DEX INC (NASDAQ), AESTHETIC MEDICAL INT HLDGS GRP LTD SPON ADS EACH REP 3 ORD SHS (NASDAQ), ONCOSEC MEDICAL INCORPORATED (NASDAQ), CONCORD MEDICAL SERVICES HLDGS LTD ADS EACH 1 REPR 3 ORD SHS (USD0.0001) (NYSE), RAILY AESMED (HKEx), KATO (HK) HLDGS (HKEx), UMP (HKEx), Diagnos Laboratorium Utama Tbk. (IDX), BARD1 LIFE SCIENCES LTD (ASX), ORTHOCELL LIMITED (ASX), SPLASH BEVERAGE GROUP INC (NYSE American), BIOCEPT INC (NASDAQ), HUMAN HEALTH (HKEx), MHCARE (Bursa), NOVO INTEGRATED SCIENCES INC (NASDAQ), KDH (SET), GBS INC (NASDAQ), IMAC HOLDINGS INC (NASDAQ), CHINA HEALTH (HKEx), D (SET), GUARDION HEALTH SCIENCES INC (NASDAQ), BCAL DIAGNOSTICS LIMITED (ASX), TOTAL BRAIN LTD (ASX), REPUBLIC HC (HKEx), SMILE (Bursa), AMERICAN SHARED HOSPITAL SERVICES (NYSE American), WAH YAN-NEW (HKEx), RMH HOLDINGS (HKEx), MEDINET GROUP (HKEx), MOHO RESOURCES NL (ASX), SMILES INCLUSIVE LTD (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.010
-2.50 %
10 Days --0.005
-1.27 %
20 Days --0.010
-2.50 %
Medium Term Return 3 Months 0.007-0.020
-3.17 %
6 Months 0.015-0.040
-5.81 %
1 Year 0.021+0.010
+8.16 %
Long Term Return 2 Years 0.034-0.125
-17.67 %
3 Years 0.054-0.220
-27.21 %
5 Years 0.106-0.112
-1.20 %
Annualised Return Annualised --
-0.24 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.360 - 0.460 Change From 1 Year Low +0.030 % Change From 1 Year Low (%) +8.33
Change From 1 Year High -0.070 % Change From 1 Year High (%) -15.22
2 Years Range 0.330 - 0.535 Change From 2 Years Low +0.060 % Change From 2 Years Low (%) +18.18
Change From 2 Years High -0.145 % Change From 2 Years High (%) -27.10
5 Years Range 0.330 - 0.950 Change From 5 Years Low +0.060 % Change From 5 Years Low (%) +18.18
Change From 5 Years High -0.560 % Change From 5 Years High (%) -58.95
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

TalkMed Group Limited is a Singapore-based investment holding company. The Company's principal activities are the provision of medical oncology services and stem cell transplant services. The Company's segments include Oncology services and Stem cells services. Its doctors provide tertiary healthcare services in the fields of medical oncology, stem cell transplant and palliative care to the oncology patients in the private sector in Singapore through Parkway Cancer Centre (PCC). Its clinical functions include attending to patients, examination and administering medical treatment to patients and performing minor outpatient surgical procedures, prescribing medicines and investigations, such as laboratory tests or diagnostic procedures. These clinical functions also include the review of investigation results and follow-up care with the patient. It provides medical oncology services and palliative care services with approximately 13 doctors at over eight clinics.

IPO Performance

Listing Date 30 Jan 2014 Full Subscription Rate (x) -
No of Placement Shares (M) 105.14 No of Public Offer Shares (M) - Public Offer Subscription Rate (x) -
IPO Price (SGD) a 0.100 First Day Close (SGD) a 0.410 First Week Close (SGD) a 0.355
Current vs IPO Price (%) +290.00 First Day Gain (%) +310.00 First Week Gain (%) +255.00
Notes:
  1. Adjusted for the following: Bonus Issue 1 for 1 on 28/04/2017

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2020 Dec 2020 Part 1(0.87 MB)
Annual Report 2019 Dec 2019 Part 1(0.97 MB)
Part 2(0.33 MB)
Annual Report 2018 Dec 2018 Part 1(4.85 MB)
Part 2(0.01 MB)
Annual Report 2017 Dec 2017 Part 1(1.86 MB)
Part 2(0.01 MB)
Annual Report 2016 Dec 2016 Part 1(1.77 MB)
Annual Report 2015 Dec 2015 Part 1(1.71 MB)
Annual Report 2014 Dec 2014 Part 1(0.70 MB)
Annual Report 2013 Dec 2013 Part 1(1.77 MB)
IPO Prospectus
IPO Prospectus 2014 Jan 2014 Part 1(1.21 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
28 Sep 2021 0.390 0.390 0.390 0.390 - -
27 Sep 2021 0.390 0.390 0.390 0.390 2,000 0.3900
24 Sep 2021 0.390 0.390 0.390 0.390 4,900 0.3900
23 Sep 2021 0.400 0.400 0.400 0.400 - -
22 Sep 2021 0.400 0.400 0.400 0.400 - -
21 Sep 2021 0.400 0.400 0.400 0.400 - -
20 Sep 2021 0.400 0.400 0.400 0.400 - -
17 Sep 2021 0.400 0.400 0.400 0.400 - -
16 Sep 2021 0.400 0.400 0.400 0.400 - -
15 Sep 2021 0.400 0.400 0.400 0.400 2,400 0.4000
14 Sep 2021 0.395 0.395 0.395 0.395 1,200 0.3950
13 Sep 2021 0.395 0.395 0.395 0.395 - -
10 Sep 2021 0.395 0.395 0.395 0.395 - -
09 Sep 2021 0.400 0.400 0.395 0.395 13,700 0.3986
08 Sep 2021 0.395 0.395 0.395 0.395 3,900 0.3950
07 Sep 2021 0.395 0.395 0.395 0.395 - -
06 Sep 2021 0.395 0.395 0.395 0.395 5,000 0.3950
03 Sep 2021 0.395 0.400 0.395 0.395 10,000 0.3972
02 Sep 2021 0.395 0.395 0.395 0.395 - -
01 Sep 2021 0.395 0.395 0.395 0.395 1,000 0.3950
31 Aug 2021 0.400 0.405 0.400 0.400 13,000 0.4018
30 Aug 2021 0.405 0.405 0.405 0.405 - -
Summary
Current 2 Weeks
(15 Sep 2021 to 28 Sep 2021)
0.400 0.400 0.390 0.390 9,300 -
Previous 2 Weeks
(01 Sep 2021 to 14 Sep 2021)
0.395 0.400 0.390 0.395 34,800 -
4 Weeks from
(03 Aug 2021 to 31 Aug 2021)
0.400 0.400 0.390 0.400 205,200 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.